Clinical Trial Update: Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy with or without bevacizumab in patients with resected stage IB-IIIA non-small cell lung cancer. Results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Phase 3 | Status: COMPLETED | Results posted: 2018-02-14